Johnson Outdoors Inc. (JOUT) At $63.93 Forms Top; Ibio (IBIO) Has 1.33 Sentiment

iBio, Inc. (NYSEAMERICAN:IBIO) Logo

Ibio Inc (IBIO) investors sentiment increased to 1.33 in Q4 2017. It’s up 0.08, from 1.25 in 2017Q3. The ratio has increased, as 4 hedge funds increased and opened new stock positions, while 3 cut down and sold stakes in Ibio Inc. The hedge funds in our database now hold: 2.71 million shares, down from 2.98 million shares in 2017Q3. Also, the number of hedge funds holding Ibio Inc in top ten stock positions was flat from 0 to 0 for the same number . Sold All: 2 Reduced: 1 Increased: 3 New Position: 1.

Johnson Outdoors Inc. (JOUT) formed multiple top with $69.68 target or 9.00% above today’s $63.93 share price. Johnson Outdoors Inc. (JOUT) has $631.41 million valuation. The stock increased 0.85% or $0.54 during the last trading session, reaching $63.93. About 37,762 shares traded or 6.27% up from the average. Johnson Outdoors Inc. (NASDAQ:JOUT) has risen 71.02% since April 14, 2017 and is uptrending. It has outperformed by 59.47% the S&P500.

Bank Of America Corp De holds 0% of its portfolio in iBio, Inc. for 4,000 shares. Bank Of New York Mellon Corp owns 73,865 shares or 0% of their US portfolio. Moreover, Blackrock Inc. has 0% invested in the company for 175,632 shares. The Ohio-based Fifth Third Bancorp has invested 0% in the stock. Geode Capital Management Llc, a Massachusetts-based fund reported 342,667 shares.

The stock decreased 5.64% or $0.011 during the last trading session, reaching $0.1841. About 1.11M shares traded. iBio, Inc. (IBIO) has declined 47.72% since April 14, 2017 and is downtrending. It has underperformed by 59.27% the S&P500.

iBio, Inc., a biotechnology company, focuses on developing and commercializing pharmaceutical product applications using its platform in the United States and internationally. The company has market cap of $21.34 million. The Company’s lead therapeutic candidate is IBIO-CFB03 for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and other fibrotic diseases. It currently has negative earnings. It is also developing vaccine candidates for third parties.

Analysts await Johnson Outdoors Inc. (NASDAQ:JOUT) to report earnings on May, 4. They expect $1.45 EPS, up 4.32% or $0.06 from last year’s $1.39 per share. JOUT’s profit will be $14.32M for 11.02 P/E if the $1.45 EPS becomes a reality. After $0.66 actual EPS reported by Johnson Outdoors Inc. for the previous quarter, Wall Street now forecasts 119.70% EPS growth.

Since December 13, 2017, it had 0 buys, and 3 insider sales for $519,334 activity. 2,985 shares valued at $183,655 were sold by PYLE THOMAS F JR on Wednesday, December 13. Sheahan Richard Case sold 4,434 shares worth $273,369. The insider Johnson David W sold 1,000 shares worth $62,310.

Investors sentiment decreased to 1.14 in Q4 2017. Its down 0.37, from 1.51 in 2017Q3. It worsened, as 11 investors sold Johnson Outdoors Inc. shares while 38 reduced holdings. 16 funds opened positions while 40 raised stakes. 6.04 million shares or 1.45% more from 5.95 million shares in 2017Q3 were reported. Pub Employees Retirement Systems Of Ohio holds 0% of its portfolio in Johnson Outdoors Inc. (NASDAQ:JOUT) for 6,465 shares. Lsv Asset Mgmt invested in 79,020 shares or 0.01% of the stock. Northern invested in 78,929 shares or 0% of the stock. Axa has invested 0% in Johnson Outdoors Inc. (NASDAQ:JOUT). Essex Invest Mngmt Ltd Liability Co invested 0.16% in Johnson Outdoors Inc. (NASDAQ:JOUT). Ajo Lp reported 0.01% in Johnson Outdoors Inc. (NASDAQ:JOUT). Balyasny Asset Mngmt Ltd Company owns 4,282 shares or 0% of their US portfolio. Bluestein R H & Com reported 5,000 shares or 0.02% of all its holdings. Spark Inv Ltd Co has 28,300 shares for 0.09% of their portfolio. Moreover, First Manhattan has 0% invested in Johnson Outdoors Inc. (NASDAQ:JOUT) for 400 shares. Cornerstone Cap Management Limited Company has invested 0.02% in Johnson Outdoors Inc. (NASDAQ:JOUT). Panagora Asset Mgmt Inc accumulated 0% or 13,718 shares. Vanguard Gru has 220,899 shares for 0% of their portfolio. Goldman Sachs invested in 19,234 shares or 0% of the stock. Hillsdale Investment Mgmt holds 0.21% or 20,820 shares.

Johnson Outdoors Inc. (NASDAQ:JOUT) Institutional Positions Chart